DFDA

Long-term Low-dose Macrolide Antibiotics (e.g., Azithromycin)

Treatment for Chronic Sinusitis

Typical Dosage: Azithromycin 250mg 3 times per week

Effectiveness
70%
Safety Score
65%
Clinical Trials
35
Participants
6K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
Azithromycin 250mg 3 times per week
Time to Effect
6-12 weeks
Treatment Duration
3-6 months
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$300
Monitoring:$150
Side Effect Mgmt:$100
Total Annual:$550
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATE
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$917
Cost per Remission
$5,500
Long-term Low-dose Macrolide Antibiotics (e.g., Azithromycin) Outcomes

for Chronic Sinusitis

Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+60%
Remission Rate
+10%
Common Side Effects
Gastrointestinal upset
+15%
Hearing disturbances
+3%
QTc prolongation
+1%

Sources:

researchgate.net
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov